Jacob L Glass

9PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Bio-fluidsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

|Jan 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.

Pallavi Galera, Deepika Dilip, Andriy Derkach

|Sep 30, 2024
The power and perils of large language models in haematology.

Jacob Glass, Olivier Elemento

|Jan 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Andrew J Dunbar, Robert L Bowman, Young C Park

|Nov 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticity.

Pallavi Galera, Deepika Dilip, Andriy Derkach

|May 04, 2023
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.

Joseph G W McCarter, David Nemirovsky, Christopher A Famulare

Pageof 2

Frequent Collaborators

5 joint publications

Wenbin Xiao

4 joint publications

Mark B Geyer

3 joint publications

Deepika Dilip

3 joint publications

Andriy Derkach